• FirefoxInstall the new Firefox »
  •  Dow Down 1.11% Nasdaq Down 0.94%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    6.78 Down 0.32(4.51%) Mar 31, 4:00PM EDT
    |After Hours : 6.78 0.00 (0.00%) Mar 31, 4:36PM EDT
    Add to Portfolio
    Prev Close:7.10
    Open:7.01
    Bid:6.67 x 100
    Ask:7.05 x 1000
    1y Target Est:13.80
    Beta:1.52
    Earnings Date:May 4 - May 8 (Est.)
    Day's Range:6.77 - 7.07
    52wk Range:3.05 - 13.26
    Volume:896,807
    Avg Vol (3m):501,270
    Market Cap:262.21M
    P/E (ttm):N/A
    EPS (ttm):-0.41
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 4.51%262.21M
    BIIBDown 2.17%99.06B
    LGNDUp 1.15%1.51B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.99
    Quarterly EPS Est (Mar-15) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback